Global pharmaceutical packaging market is expected to reach USD 360.57 Bn by 2033, from USD 163.11 Bn in 2026, exhibiting a compound annual growth rate (CAGR) of 12.0% during the forecast period (2026-2033).
The global pharmaceutical packaging market is fueled by the growing need for secure and efficient drug delivery methods, increased pharmaceutical production, and high standards of regulations regarding product protection and traceability. The increased use of prescription drugs, biologics, and over-the-counter drugs, along with developing health care infrastructure, will continue to boost the pharmaceutical packaging market growth. Innovations in the form of smart packaging, sustainability innovations, and anti-counterfeiting technologies are also propelling growth in this market. Raw material price changes and regulatory compliance issues are among the challenges faced in this market. Recyclable packaging materials and personalized medicine packaging represent some of the opportunities in the market.
By Material, the Plastic & Polymers are projected to hold the largest share of the pharmaceutical packaging market with 53.5% in 2026 due to their high durability, lightweight, cost-effectiveness, and excellent moisture and chemical resistance properties. Polyethylene, polypropylene, and PVC materials are widely used in pharmaceutical bottles, blisters, containers, and closures as they not only protect the product but also provide tamper evidence and child-resistance packaging options. The easy manufacturing process and suitability with various pharmaceutical formulations help in maintaining the dominance of these materials in the market.
By Product, the Blister Packs are expected to hold the largest share of the market due to its capability to provide excellent product protection, precise unit-dose dispensing, and increased shelf-life of pharmaceutical products. Blister packaging provides an excellent barrier against moisture, light, and contamination, along with improved patient compliance due to organized dose dispensing. The increasing use of oral solid dosage forms and the rising regulatory requirements for safety and traceability of the products will fuel the use of blister packs.
The North American market will dominate the pharmaceutical packaging market in 2026 with a market share of 39.0%, due to the presence of highly developed pharmaceutical manufacturing industry, use of innovative technologies, presence of robust regulations and rising investments in biopharmaceuticals and specialty drugs manufacturing. Growing demand for tamper evident packaging and adoption of smart packaging systems make the market in North America dominate the market. Europe is another dominant player in the market, due to stringent patient safety regulations, rising adoption of eco-friendly packaging and rising adoption of serialization technologies, presence of major pharmaceutical companies in countries like Germany, France, the Netherlands and Russia.
Prominent Players in the Pharmaceutical Packaging Market
-
Amcor plc
Company Overview
- Headquarters: Zurich, Switzerland
- Establishment Year: 2019
- Employee Strength: Approximately 41,000 employees
- Leadership: Mr. Peter Konieczny, Chief Executive Officer
- Core Services/Products: Pharmaceutical packaging, flexible packaging, rigid packaging, blister packaging, medical packaging, healthcare packaging, and sustainable packaging solutions.
SWOT Analysis
- Strengths
- Global leader in pharmaceutical and healthcare packaging solutions.
- Strong focus on sustainable and recyclable packaging innovations.
- Weaknesses
- Business performance is sensitive to raw material price fluctuations.
- High dependence on plastic-based packaging materials.
- Opportunities
- Rising demand for biologics and specialty pharmaceutical packaging.
- Expansion of smart, sustainable, and high-barrier packaging solutions.
- Threats
- Increasing environmental regulations on plastic packaging.
- Intense competition from global packaging manufacturers.
-
Berry Global Inc.
Company Overview
- Headquarters: Evansville, Indiana, United States
- Establishment Year: 1967
- Employee Strength: Approximately 34,000 employees
- Leadership: Mr. Kevin J. Kwilinski, Chief Executive Officer
- Core Services/Products: Pharmaceutical packaging, plastic containers, closures, healthcare packaging, flexible packaging, medical components, and specialty packaging solutions.
SWOT Analysis
- Strengths
- Portfolio of plastics for healthcare and pharmaceutical packaging.
- Global presence in manufacturing and distribution facilities.
- Weaknesses
- Sources of resin/polymer raw materials used.
- Environmental issues associated with plastic packaging.
- Opportunities
- Higher demand for recyclable and lighter pharmaceutical packages.
- Entry into developing pharmaceutical manufacturing markets.
- Threats
- Highly volatile prices of raw materials.
- Stringent regulation against plastic packaging waste.
-
Becton, Dickinson and Company (BD)
Company Overview
- Headquarters: Franklin Lakes, New Jersey, United States
- Establishment Year: 1897
- Employee Strength: Approximately 70,000 employees
- Leadership: Mr. Tom Polen, Chairman, Chief Executive Officer & President
- Core Services/Products: Prefillable syringes, pharmaceutical packaging systems, drug delivery devices, medical devices, diagnostic systems, and injection technologies.
SWOT Analysis
- Strengths
- Global market leader in packaging of drugs and medical products.
- Capabilities for innovations backed by strong knowledge of healthcare industry.
- Weaknesses
- High premium prices on innovative pharmaceutical packages.
- Very high dependency on approvals of medical devices and products.
- Opportunities
- Increasing demand for injectable biologicals and prefilled syringes.
- Sales and marketing of advanced drug delivery and vaccine packaging devices.
- Threats
- Demand for regulatory compliance.
- Competition from medical technology companies around the world.
-
Owens-Illinois Inc. (O-I Glass, Inc.)
Company Overview
- Headquarters: Perrysburg, Ohio, United States
- Establishment Year: 1903
- Employee Strength: Approximately 21,000 employees
- Leadership: Mr. Gordon Hardie, Chief Executive Officer
- Core Services/Products: Glass pharmaceutical containers, glass bottles, vials, ampoules, specialty glass packaging, and sustainable packaging solutions.
SWOT Analysis
- Strengths
- Largest producer of superior quality glass packaging.
- Efficient in manufacturing sustainable and recyclable glass packaging.
- Weaknesses
- Transportation and manufacturing expenses are more compared to plastic packaging.
- Products made from glass are heavy and fragile.
- Opportunities
- Growing need for glass vials used in pharmaceutical industry and drug injection packaging.
- Growing inclination towards sustainable and recyclable packaging.
- Threats
- Secure plastic packaging competition.
- High cost of energy and raw materials for glass production.
